{"id":"W2741997980","doi":"10.1158/1538-7445.am2017-1087","title":"Abstract 1087: CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Midostaurin; Cytarabine; Viability assay; Pharmacology; Flow cytometry; Ex vivo; Cancer research; In vivo; Leukemia; Myeloid leukemia; Medicine; Chemistry; Cell; Biology; Internal medicine; Immunology; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598215,0.0004958284,0.0005652975,0.000300347,0.0001624772,0.0003306176,0.0003188949,0.0003869049,0.002648176],"category_scores_gemma":[0.0001413142,0.0001496349,0.0003263601,0.0002101679,0.0002326629,0.0002171157,0.0002208743,0.000662227,0.0004460795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003412445,"about_ca_system_score_gemma":0.0004182551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001387656,"about_ca_topic_score_gemma":0.001654853,"domain_scores_codex":[0.9998384,0.00003845192,0.00001509731,0.00002290516,0.00003517328,0.00004998798],"domain_scores_gemma":[0.9999233,0.00001988747,0.00001416787,0.000007467536,0.000007666497,0.00002749765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003259735,0.0008352309,0.0004038258,0.0002506424,0.00006344532,0.0001551024,0.0000705417,0.000801869,0.981353,0.0001846594,0.000874762,0.01174724],"study_design_scores_gemma":[0.000463042,0.009400413,0.004526251,0.0000226043,0.000101039,0.000285015,0.00003051855,0.001861211,0.9794779,0.00003620547,0.003782292,0.00001348862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944363,0.001660928,0.0005132867,0.000194459,0.00007339857,0.00009067794,0.0005312825,0.0001263339,0.002373275],"genre_scores_gemma":[0.9969589,0.0005653226,0.0008004308,0.00005920405,0.0000243,0.00004244666,0.0005129066,0.0000105318,0.001026007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002648176,"threshold_uncertainty_score":0.008859038,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05326379269320802,"score_gpt":0.3919127049360759,"score_spread":0.3386489122428679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}